Latest Content

CURE spoke with breast cancer survivor Mary Royal about her cancer journey in a multi-part interview.

Most people think of anniversaries as happy things. But there are other anniversaries that commemorate less pleasant events. Some anniversaries are a mix of pleasant and unpleasant.

In a recent CURE conversation, Charles Walker shared how months of unexplained fatigue and back pain ultimately led to a life-altering diagnosis.

CURE spoke with Dr. Kathie-Ann Joseph about the importance of personalized, multidisciplinary treatments when caring for patients with breast cancer.

A phase 2 trial found oxybutynin safely reduced the frequency and severity of hot flashes in men receiving hormone therapy for prostate cancer.

The U.S. FDA has granted Regenerative Medicine Advanced Therapy designation to KB707 for the treatment of advanced/metastatic non-small cell lung cancer.

In CATNON, 12 cycles after radiation extended median survival past 12 years in IDH-mutant disease while concurrent dosing showed no benefit.

Dr. Sue Hwang explains how she went from a care provider who helped others through their cancer journeys to a patient facing a cancer diagnosis of her own.

Drs. Miller, Orringer and Yang explain IDH testing, treatment options, quality of life and caregiver roles for patients with IDH-mutant glioma.

USC doctors say careful staging and tumor testing help younger patients choose surgery and targeted treatments based on their cancer.

Hodgkin lymphoma is a cancer of the lymphatic system, which includes lymph nodes, the spleen and immune cells that help the body fight infection.

Stage 3 ccRCC is locally advanced but often treatable. Learn how it is diagnosed, treated, and managed to support informed decisions with your care team.

CURE sat down with Dr. Kathie-Ann Joseph to discuss surgical advancements for individuals with breast cancer.